Acute intoxication following massive bupropion sniffing: A case report
https://doi.org/10.4081/ecj.2021.10037
Accepted: 6 December 2021
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Bupropion intranasal misuse potential should be considered in the suspect of sympathomimetic syndrome for illicit drug or medication intoxication. A 31-year-old man was admitted for intranasal misuse of 30 crushed tablets of bupropion with adrenergic mild presentation. Lorazepam infusion was started with complete clinical resolution. Further forensic investigations detected a bupropion serum and urine concentration levels at 18 hours from intake of 1905.26 ng/mL and 2001.57 ng/mL, respectively. This case of intranasal bupropion misuse shared only some features with oral overdose, despite a plasma concentration five times higher than the lowest toxic level. Nasal bupropion snorting in chronic users could have lower toxicity compared to other snorted stimulants but symptomatic treatment remains the gold standard for preventing complications. Bupropion misuse might rapidly become a concerning issue and monitoring by healthcare professionals is needed.
Chiappini S, Schifano F. What about “Pharming”? Issues regarding the misuse of prescription and over-the-counter drugs. Brain Sci 2020;10:736. DOI: https://doi.org/10.3390/brainsci10100736
Huecker MR, Smiley A, Saadabadi A. Bupropion. StatPearls 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470212/
Trivedi MH, Walker R, Ling W, et al. Bupropion and naltrexone in methamphetamine use disorder. New Engl JMed 2021;384:140–53. DOI: https://doi.org/10.1056/NEJMoa2020214
Costa R, Oliveira NG, Dinis-Oliveira RJ. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metabolism Rev 2019;51:293–313.
Naglich AC, Brown ES, Adinoff B. Systematic review of preclinical, clinical, and post-marketing evidence of bupropion misuse potential. Am J Drug Alcohol Abuse. 2019;45:341–54. DOI: https://doi.org/10.1080/00952990.2018.1545023
Starr P, Klein-Schwartz W, Spiller H, et al. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am JEmerg Med 2009;27:911–5. DOI: https://doi.org/10.1016/j.ajem.2008.07.004
Morazin F, Lumbroso A, Harry P, et al. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clinical Toxicol 2007;45:794–7. DOI: https://doi.org/10.1080/15563650701665076
Stassinos GL, Klein-Schwartz W. Bupropion “abuse” reported to US Poison Centers. JAddict Med 2016;10:357–62. DOI: https://doi.org/10.1097/ADM.0000000000000249
Hilliard WT, Barloon L, Farley P, et al. Bupropion diversion and misuse in the correctional facility. JCorrect Health Care 2013;19:211–7. DOI: https://doi.org/10.1177/1078345813486448
Welsh CJ, Doyon S. Seizure induced by insufflation of bupropion. New Engl JMed 2002:347:951. DOI: https://doi.org/10.1056/NEJM200209193471222
Sheridan DC, Lin A, Zane Horowitz B. Suicidal bupropion ingestions in adolescents: increased morbidity compared with other antidepressants. Clinical Toxicol 2018;56:360–4. DOI: https://doi.org/10.1080/15563650.2017.1377839
Baribeau D, Araki KF. Intravenous bupropion. JAddict Med 2013;7:216–7. DOI: https://doi.org/10.1097/ADM.0b013e3182824863
Strike M, Hatcher S. Bupropion injection resulting in tissue necrosis and psychosis. JAddict Med 2015;9:246–50. DOI: https://doi.org/10.1097/ADM.0000000000000114
Farkas J. Bupropion intoxication.Internet Book of Critical Care. 2019. Available from: https://emcrit.org/ibcc/bupropion
Norwegian Institute of Public Health. ATC/DDD Index. WHO Collaborating Centre for Drug Statistics Methodology. 2020.
Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. Clinical Therapeutics. 2005;27:1685–95. DOI: https://doi.org/10.1016/j.clinthera.2005.11.011
Preskorn SH. Antidepressant response and plasma concentrations of bupropion. JClinPsychiat 1983;44:137–9.
Nelson LS, Howland MA, Lewin NA, et al. Cocaine. Nelson L.S., & Howland M, &Lewin N.A., & Smith S.W., &Goldfrank L.R., & Hoffman R.S.(Eds.), Goldfrank'sToxicologic Emergencies, 11e. McGraw Hill. Available from: https://accessemergencymedicine.mhmedical.com/content.aspx?bookid=2569§ionid=210259752
Yoon G, Westermeyer J. Intranasal bupropion abuse. Am JAddict 2013;22:180. DOI: https://doi.org/10.1111/j.1521-0391.2013.00329.x
Costa R, Oliveira NG, Dinis-Oliveira RJ. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metab Rev 2019;51:293-313. DOI: https://doi.org/10.1080/03602532.2019.1620763
Casey ER, Scott MG, Tang S, Mullins ME. Frequency of false positive amphetamine screens due to bupropion using theSyva Emit II Immunoassay. JMed Toxicol 2011;7:105–8. DOI: https://doi.org/10.1007/s13181-010-0131-5
Jolly TS, Singh J, Baweja R. Bupropion-Induced Severe Leukocytosis. Cureus 2020;12:e11083. DOI: https://doi.org/10.7759/cureus.11083
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
